Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETH47 in Asthma Following Rhinovirus Challenge
NCT07059767Phase 2Completed
- Sponsor
- Ethris GmbH
- Start
- Jun 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ETH47 in asthma, sponsored by Ethris GmbH. Started Jun 2025; status: completed.
02
Drugs
ETH47
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07059767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07059767.